Technical Data
C7849-09D
COMP (Cartilage Oligomeric Matrix Protein, Cartilage Oligomeric Matrix Protein Precursor, EDM1, EPD1, Epiphyseal Dysplasia 1, Epiphyseal Dysplasia 1 Multiple, MED, MGC13181, MGC149768, PSACH, Pseudoachondroplasia, THBS5, Thrombospondin 5)
Description:
Applications:
Suitable for use in ELISA, Western Blotting. Other applications not tested.

Recommended Dilution:
Western Blotting: 1:1000-1:2000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at 4C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgYSerum
SizeStorageShippingSourceHost
1mg-20CBlue IceRatChicken
Concentration:
~1mg/ml
Immunogen:
Recombinant rat COMP (Fragment T3+TC)
Purity:
Serum
Form
Supplied as a lyophilized powder in PBS, pH 7.2. Reconstitute in ddH2O.
Specificity:
Recognizes rat Cartilage Oligomeric Matrix Protein (COMP). Species Crossreactivity: Human, mouse.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Spitznagel L, Nitsche DP, Paulsson M, Maurer P, Zaucke F. Characterization of a pseudoachondroplasia-associated mutation (His587-->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP). Biochem J. 2004 Jan 15; 377(Pt 2): 479-87.